Landing
European Hematology Association (EHA) 2024
Improvement in Iron Overload With Pegcetacoplan Therapy in Patients With Paroxysmal Nocturnal Hemoglobinuria Previously Treated With Eculizumab
Thrombosis and Meningococcal Infection Rates in Pegcetacoplan Patients With Paroxysmal Nocturnal Hemoglobinuria in the Post-marketing Setting
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.